1092 related articles for article (PubMed ID: 12027461)
1. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
2. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells.
Avila E; Díaz L; Halhali A; Larrea F
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):115-9. PubMed ID: 15225757
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.
Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M
Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427
[TBL] [Abstract][Full Text] [Related]
4. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24).
Inouye K; Sakaki T
Biotechnol Annu Rev; 2001; 7():179-94. PubMed ID: 11686044
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells.
Khorchide M; Lechner D; Cross HS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):167-72. PubMed ID: 15860259
[TBL] [Abstract][Full Text] [Related]
8. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells.
Armbrecht HJ; Hodam TL; Boltz MA
Arch Biochem Biophys; 2003 Jan; 409(2):298-304. PubMed ID: 12504896
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
Anderson PH; O'Loughlin PD; May BK; Morris HA
Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
[TBL] [Abstract][Full Text] [Related]
10. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
Anderson PH; O'Loughlin PD; May BK; Morris HA
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells.
Lechner D; Kállay E; Cross HS
Mol Cell Endocrinol; 2007 Jan; 263(1-2):55-64. PubMed ID: 17029768
[TBL] [Abstract][Full Text] [Related]
12. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.
Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M
Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
Miller GJ; Stapleton GE; Hedlund TE; Moffat KA
Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.
Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts.
Avila E; Díaz L; Barrera D; Halhali A; Méndez I; González L; Zuegel U; Steinmeyer A; Larrea F
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):90-6. PubMed ID: 17079137
[TBL] [Abstract][Full Text] [Related]
18. Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.
Kállay E; Bises G; Bajna E; Bieglmayer C; Gerdenitsch W; Steffan I; Kato S; Armbrecht HJ; Cross HS
Carcinogenesis; 2005 Sep; 26(9):1581-9. PubMed ID: 15905206
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
20. The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention.
Cross HS; Bises G; Lechner D; Manhardt T; Kállay E
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):121-8. PubMed ID: 16081282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
